No, not through a normal prescription. Ozempic is semaglutide, an established prescription medicine, and retatrutide is a different drug that is still investigational, meaning it is being studied in clinical trials and is not a standard option for prescribing. Any change to your Ozempic should go through your prescriber, and your first step is to ask what you can and cannot do right now.
Can I switch from Ozempic to retatrutide right now?
Ozempic’s active ingredient is semaglutide, a GLP-1 receptor agonist. Harvard Health’s Ozempic explainer says GLP-1 medicines like it “have gained attention for their role in treating type 2 diabetes and promoting weight loss.” Retatrutide works differently. PURE Medical Spa’s comparison page describes it as targeting GIP, GLP-1 and glucagon receptors, three pathways instead of one.
Status is the deciding point. PURE Medical Spa’s page says retatrutide is “still an investigational drug being studied in clinical trials” and that it was not FDA approved as of March 25, 2026. Peptidesearch.io’s comparison says that “Switching while Retatrutide remains investigational is not a standard clinical option.”
| Item | Ozempic | Retatrutide |
|---|---|---|
| What it is | Semaglutide, a GLP-1 receptor agonist | Investigational triple agonist; PURE Medical Spa says it targets GIP, GLP-1 and glucagon receptors |
| Standing | Established prescription medicine; Harvard Health links it to type 2 diabetes and weight loss | Not FDA approved as of March 25, 2026 (per PURE Medical Spa) |
| How you get it | By prescription | Standard prescription switching is not yet possible, according to peptidesearch.io; access is through clinical trials |
Peptidesearch.io also projects FDA approval for retatrutide in 2027 to 2028. That is a seller’s projection, not a regulator’s decision, so treat it as a date to confirm, not one to plan around.
What the retatrutide trial results mean for you
A trial result is not an approval, and it does not create a prescription route. PURE Medical Spa’s page describes the phase 2 trial behind retatrutide’s weight data as one published in The New England Journal of Medicine, which ran for 48 weeks in adults with obesity.
Take the news to your prescriber and ask what it means for your own care. Trial results show what a drug did in the people studied. They do not decide what you can get.
Can I switch the day I take my last Ozempic dose?
There is no standard timing for a switch to retatrutide, and the timing question belongs to your prescriber. Two commercial peptide pages disagree on whether a gap is needed. Platinum Biolabs’ blog says a washout is optional, while peptidesearch.io says weekly GLP-1 drugs typically require a washout. When sellers disagree, bring the question to your prescriber rather than picking the answer you like.
Do not stop Ozempic on your own. Cleveland Clinic’s GLP-1 agonist guide lists talking with your provider when you are thinking of stopping the medication, and when it is not working for you.
Is a retatrutide “research” supply from a seller a safe switch?
No, and the seller pages themselves point to why. Platinum Biolabs’ disclaimer says its products are “intended strictly for laboratory and research use only.” PURE Medical Spa’s page says the FDA has warned consumers about illegally sold unapproved GLP-1-related products containing retatrutide.
The National Academy of Medicine’s GLP-1 basics page says compounded GLP-1s may be improperly stored, and some may be fraudulent, missing high-quality active ingredients. Its summary of the FDA’s advice is to take these drugs only as prescribed and to fill prescriptions at a state-licensed pharmacy.
If you have seen homemade retatrutide protocols online, our homemade retatrutide protocols page sorts the claims from the facts, and our government homemade retatrutide protocol page covers what is being claimed.
What should I ask my prescriber before any change?
Bring these questions to your next appointment. They turn the news into a plan you can act on.
- Is retatrutide open to me through a clinical trial, and what would a trial require?
- What is the current FDA status of retatrutide, and do you expect it to become prescribable?
- What should I do with my Ozempic prescription while I wait?
- Which side effects should prompt a call? Harvard Health lists nausea, vomiting, diarrhea, constipation and abdominal discomfort as the most common GLP-1 side effects, and headaches, increased heart rate, dizziness and fatigue as less common.
Write these down before you go. Your prescriber can tell you what is current for your own care.
By MeridianMedicalCentre.com Health Research Team
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.